People · Operator
Named in public records as an officer, director or promoter · active 2010–2013 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Intrapace Inc | — | Other Health Care | Series D+ | $179.1M | $76.8M | 2012 |
| Viracta Therapeutics, INC. | — | Biotechnology | Series C | $164.6M | $2.1B | 2010 |
Wayne Roe at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Wayne Roe on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Soon-Shiong | 1 | 16 |
| Eric Bell | 1 | 7 |
| J. Daniel Cole | 1 | 7 |
| Ivor Royston | 1 | 7 |
| TING PAU OEI | 1 | 7 |
| Martin Dieck | 1 | 7 |
| Mir Imran | 1 | 6 |
| Roger Pomerantz | 1 | 4 |
| Paul Goddard | 1 | 4 |
| James Woody | 1 | 4 |
| Ronald Berenson | 1 | 3 |
| James N. Woody | 1 | 3 |
| Barry Simon | 1 | 3 |
| Frederick Dotzler | 1 | 3 |
| Armen Shanafelt | 1 | 3 |
| MICHAEL HUANG | 1 | 2 |
| Chris Rowland | 1 | 2 |
| Eric R. Bell | 1 | 2 |
| Gur Roshwalb | 1 | 2 |
| Gary Castro | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.